STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Unilens Vision Inc. (“Unilens” or the “Company”) (Other OTC: UVIC) relating to the proposed buyout of the Company by Valeant Pharmaceuticals International, Inc. Under the terms of the transaction, Unilens shareholders are anticipated to receive $12.75